Current portion of deferred revenue 4,326 7,916
Current portion of obligations under capital leases 163 94
Current portion of long-term debt 3,890 4,425
-------------------------------------------------------------------------
Total current liabilities 17,839 21,343
-------------------------------------------------------------------------
Deferred revenue 18,142 16,593
Obligations under capital leases 5,678 5,746
Long-term debt - 3,396
-------------------------------------------------------------------------
Total liabilities 41,659 47,078
-------------------------------------------------------------------------
Shareholders' equity
Common shares, no par value, unlimited shares
authorized, 56,817,963 and 56,747,963 issued
and outstanding as at September 30, 2007 and as
at December 31, 2006, respectively 241,955 241,588
Contributed surplus 11,848 8,417
Deficit (194,988) (168,449)
Accumulated other comprehensive loss (136) -
-------------------------------------------------------------------------
Total shareholders' equity 58,679 81,556
-------------------------------------------------------------------------
100,338 128,634
-------------------------------------------------------------------------
-------------------------------------------------------------------------
| SOURCE Labopharm Inc. Copyright©2007 PR Newswire. All rights reserved |